DanCann Pharma A/S: CFO Mads Møller Kristensen and DanCann Pharma will be parting ways as of 31 May 2022
COPENHAGEN, Denmark, 28 March 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the CFO Mads Møller Kristensen and the Company will be parting ways.DanCann Pharma and CFO Mads Møller Kristensen have decided to stop the collaboration at the end of May 2022. CEO, Jeppe Krog Rasmussen, comments: “Since the appointment as CFO in April 2020, Mads has developed a well-functioning finance function from scratch, and at the same time he has been a big contributor to the development of the Company. Mads has